Abbott's heart stent gains FDA approval

01/4/2013 | Reuters

The FDA has granted Abbott Laboratories approval for its Xience Xpedition system, which the company said is targeted for immediate release in the U.S. The heart stent administers the drug everolimus to aid in the prevention of blood vessel reclogging.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ